CN108904766A - 一种治疗荨麻疹的养颜膏方及其制备方法 - Google Patents
一种治疗荨麻疹的养颜膏方及其制备方法 Download PDFInfo
- Publication number
- CN108904766A CN108904766A CN201810730242.4A CN201810730242A CN108904766A CN 108904766 A CN108904766 A CN 108904766A CN 201810730242 A CN201810730242 A CN 201810730242A CN 108904766 A CN108904766 A CN 108904766A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- nettle rash
- rhizoma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000024780 Urticaria Diseases 0.000 title claims abstract description 81
- 238000011282 treatment Methods 0.000 title claims abstract description 67
- 230000003796 beauty Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 41
- 235000019991 rice wine Nutrition 0.000 claims abstract description 28
- 239000003292 glue Substances 0.000 claims abstract description 21
- 241000282994 Cervidae Species 0.000 claims abstract description 20
- 241001550206 Colla Species 0.000 claims abstract description 19
- 241000758794 Asarum Species 0.000 claims abstract description 16
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 15
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 15
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 15
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 15
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 15
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 15
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 15
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000756943 Codonopsis Species 0.000 claims abstract description 14
- 244000203593 Piper nigrum Species 0.000 claims abstract description 14
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 14
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 14
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000013614 black pepper Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 239000001931 piper nigrum l. white Substances 0.000 claims abstract description 14
- 240000006766 Cornus mas Species 0.000 claims abstract description 13
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 13
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 13
- 240000007049 Juglans regia Species 0.000 claims abstract description 13
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 235000020234 walnut Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 21
- 238000001802 infusion Methods 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 235000012907 honey Nutrition 0.000 claims description 10
- 239000006260 foam Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims 3
- 244000000383 Allium odorum Species 0.000 claims 1
- 235000018645 Allium odorum Nutrition 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 27
- 210000004369 blood Anatomy 0.000 abstract description 26
- 201000010099 disease Diseases 0.000 abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 25
- 230000007812 deficiency Effects 0.000 abstract description 8
- 208000005171 Dysmenorrhea Diseases 0.000 abstract description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 4
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 3
- 208000011580 syndromic disease Diseases 0.000 abstract description 3
- 208000010445 Chilblains Diseases 0.000 abstract description 2
- 206010008528 Chillblains Diseases 0.000 abstract description 2
- 201000004624 Dermatitis Diseases 0.000 abstract description 2
- 206010015218 Erythema multiforme Diseases 0.000 abstract description 2
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 abstract description 2
- 208000031814 IgA Vasculitis Diseases 0.000 abstract description 2
- 206010036376 Postherpetic Neuralgia Diseases 0.000 abstract description 2
- 201000004681 Psoriasis Diseases 0.000 abstract description 2
- 208000003782 Raynaud disease Diseases 0.000 abstract description 2
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract description 2
- 206010047115 Vasculitis Diseases 0.000 abstract description 2
- 208000010668 atopic eczema Diseases 0.000 abstract description 2
- 230000015271 coagulation Effects 0.000 abstract description 2
- 238000005345 coagulation Methods 0.000 abstract description 2
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 abstract description 2
- 201000010260 leiomyoma Diseases 0.000 abstract description 2
- 206010033898 parapsoriasis Diseases 0.000 abstract description 2
- 241000905957 Channa melasoma Species 0.000 abstract 1
- 210000002683 foot Anatomy 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 15
- 238000010792 warming Methods 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 208000024376 chronic urticaria Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 206010052568 Urticaria chronic Diseases 0.000 description 10
- 241001247821 Ziziphus Species 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 241000234314 Zingiber Species 0.000 description 9
- 230000001684 chronic effect Effects 0.000 description 9
- 210000002105 tongue Anatomy 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 231100001274 therapeutic index Toxicity 0.000 description 7
- 206010033733 Papule Diseases 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010048768 Dermatosis Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 235000019082 Osmanthus Nutrition 0.000 description 3
- 241000333181 Osmanthus Species 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 239000002893 slag Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108010058861 Fibrin Fibrinogen Degradation Products Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 108010025252 Kassinin Proteins 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000208 fibrin degradation product Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229960003088 loratadine Drugs 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 208000011726 slow pulse Diseases 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 108010020067 Histaglobin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 208000009481 Laryngeal Edema Diseases 0.000 description 1
- 206010023845 Laryngeal oedema Diseases 0.000 description 1
- 206010048961 Localised oedema Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000588278 Osmanthus heterophyllus Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108010003541 Platelet Activating Factor Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000219422 Urtica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 206010046740 Urticaria cholinergic Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- -1 adrenobazonum Chemical compound 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001736 anti-fibrinolysin Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 201000005681 cholinergic urticaria Diseases 0.000 description 1
- 208000030949 chronic idiopathic urticaria Diseases 0.000 description 1
- 206010072757 chronic spontaneous urticaria Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 206010009869 cold urticaria Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000009688 danggui sini Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940080780 loratadine 10 mg Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 description 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036259 sexual stimuli Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940127230 sympathomimetic drug Drugs 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
Abstract
本发明公开了一种治疗荨麻疹的养颜膏方,包括以下原料:当归、桂枝、党参、鹿角胶、川芎、陈皮、焦神曲、山药、茵陈、益智仁、白胡椒、补骨脂、红枣、白芍、熟地、龟甲胶、柴胡、酒黄精、生姜、山萸肉、枸杞子、桑寄生、韭菜子、细辛、黄芪、肉桂、红花、苍术、杜仲、茯苓、艾叶、菟丝子、吴茱萸、香附、黄酒、龙眼肉、红糖、黑芝麻、核桃仁,本发明主要针对血虚寒凝型荨麻疹的治疗,由于体质的相关性,治疗的出发点从体质入手,还可以用于治疗证属血虚寒凝证的:顽固性湿疹、脉管炎、带状疱疹后遗神经痛、荨麻疹、过敏性紫癜、多形性红斑、雷诺氏病、手足皲裂、冻疮、寻常型银屑病、副银屑病、痹证、痛经、子宫肌瘤、痛经等多种疾病。
Description
技术领域
本发明涉及一种中医药领域,具体是一种治疗荨麻疹的养颜膏方及其制备方法。
背景技术
荨麻疹是由于皮肤、粘膜小血管扩张及渗透性增加而出现的一种局限性水肿反应,是一种常见的皮肤病。有15%~20%的人一生中至少患过一次荨麻疹。本病可以发生于任何年龄、季节,皮损可发生于任何部位。临床表现为皮肤黏膜一过性大小不等的局限性水肿性风团,伴有剧烈瘙痒、红斑,风团轻度隆起,迅速发生与消退,退后无痕迹。根据病程长短,可分为急性和慢性两种。急性者起病较急,常于短期内痊愈,病情严重可伴有心慌、烦躁、恶心、呕吐甚至血压降低等过敏性休克样症状;皮损反复发作超过六周以上者称为慢性荨麻疹。慢性者全身症状一般较急性者轻,反复发作,迁延数月,经年不断,偶可急性发作。此外,尚有由冷、热、日光、摩擦、压力等物理因素性刺激引起的特殊类型的荨麻疹,常见有人工荨麻疹、寒冷性荨麻疹、胆碱能性荨麻疹、日光性荨麻疹、压力性荨麻疹等。现代医学认为荨麻疹病因复杂,约3/4的患者找不到原因。常见的病因有药物、食物、吸入物、感染、物理因素、蚊虫叮咬、精神因素等。荨麻疹的发病机理尚未完全清楚,目前主要分免疫性和非免疫性两类。免疫性的多属Ⅰ型变态反应,其特点是反应发生迅速,一般在数分钟,甚至不到一分钟内即发生,病变可逆,缓解后常不留痕迹。其抗体通常是。肥大细胞表面的抗体与抗原发生特异性结合,引起肥大细胞脱颗粒并释放活性介质,引起荨麻疹最主要的介质是组织胺,其他介质如激肽、前列腺素、乙酰胆碱、白三烯、血小板活化因子、纤维蛋白降解产物和过敏性毒素等在荨麻疹的发病中也起着重要作用。这些介质使机体毛细血管扩张,通透性增加,平滑肌收缩,腺体分泌增加。从而产生皮肤、粘膜、消化道、呼吸道、循环系统乃至中枢神经系统的一系列症状。非免疫反应性荨麻疹是由某些物质某些药物和食物、毒素等进入体内,使补体及分解,产生及等过敏毒素,或直接刺激肥大细胞释放组胺、激肽等引起。大多数原因不明的慢性荨麻疹被称为慢性特发性荨麻疹。近年来有报道显示,在约的患者血清中测到高亲和力受体自身抗体和抗自身抗体,认为这类慢性荨麻疹发病是以自身免疫机制为基础的。目前西医治疗该病主要是抗过敏和对症治疗。对于急性荨麻疹,常用抗组胺药、维生素、钙剂等降低血管通透性,伴腹痛者给予解痉药;脓毒血症或者败血症引起者使用抗生素控制感染;伴有休克、喉头水肿及呼吸困难者予拟交感神经药物及激素等对症治疗。对于慢性荨麻疹以抗组胺药治疗为主,还有用抗纤维蛋白溶酶药物、组胺球蛋白、抑肽酶、氯化喹啉、安络血、利血平等。但西药存在不良反应较多,中断治疗易复发的不足,而根本的治疗是去除病因。中医称本病为“瘾疹”,此外尚有“鬼饭疙瘩”、“风疹块”、“风瘙瘾疹”等名。中医认为其病因多由禀赋不耐,腠理失密,外感风热、风寒、风湿之邪或饮食失节,过食辛辣、膏粱厚味之品,致脾胃失调湿热困脾,化热动风或卫外不固,汗出受风或外邪久郁化热伤及阴液或平素体弱,气血不足,加之风邪外袭,郁于皮毛肌腠之间,以致内不得疏泄外不得透达,正邪相搏而发疹,或者精神紧张而肝郁不舒,气血失和,风邪内伏而发病。临床急性荨麻疹多为实证,慢性者多虚实夹杂。《诸病源候论·风病诸候下·风瘙隐轸生疮候》曰:“人皮肤虚,为风邪所折,则起隐轸,寒多色赤,风多色白。甚者痒痛,搔之则成疮。”急性荨麻疹治疗较易,慢性荨麻疹虚实夹杂,病机复杂,长期服用汤剂不仅煎煮繁琐,口感差,且病人长期服药致依从性变差,因此在这些形式下更凸显出中医中药的优势,以往常用的内服中药有汤剂和丸剂,汤剂煎煮繁琐、口感差,患者依从性差,而丸剂吸收、显效慢、药味药量固定,难以达到辩证论治治疗效果。
发明内容
本发明的目的在于提供一种治疗荨麻疹的养颜膏方及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种治疗荨麻疹的养颜膏方,包括以下重量份数的原料:当归10-20份、桂枝10-20份、党参10-20份、鹿角胶5-20份、川芎5-20份、陈皮2-10份、焦神曲10-20份、山药30-50份、茵陈10-30份、益智仁10-30份、白胡椒1-6份、补骨脂10-20份、红枣30-60份、白芍15-50份、熟地15-40份、龟甲胶2-8份、柴胡5-15份、酒黄精10-30份、生姜10-20份、山萸肉10-20份、枸杞子20-45份、桑寄生20-40份、韭菜子5-20份、细辛5-20份、黄芪20-40份、肉桂2-10份、红花1-8份、苍术2-10份、杜仲10-20份、茯苓10-20份、艾叶2-8份、菟丝子10-30份、吴茱萸1-7份、香附10-20份、黄酒350-600份、龙眼肉100-200份、红糖30-70份、黑芝麻30-70份、核桃仁70-150份、水适量。
作为本发明进一步的方案:包括以下重量份数的原料:当归15份、桂枝15份、党参15份、鹿角胶10份、川芎10份、陈皮5份、焦神曲15份、山药40份、茵陈20份、益智仁20份、白胡椒3份、补骨脂15份、红枣45份、白芍30份、熟地30份、龟甲胶5份、柴胡10份、酒黄精20份、生姜15份、山萸肉15份、枸杞子30份、桑寄生30份、韭菜子10份、细辛5份、黄芪30份、肉桂5份、红花3份、苍术5份、杜仲15份、茯苓15份、艾叶5份、菟丝子20份、吴茱萸3份、香附15份、黄酒500份、龙眼肉150份、红糖50份、黑芝麻50份、核桃仁100份、水适量。
作为本发明再进一步的方案:还包括蜂蜜10-20份。
一种治疗荨麻疹的养颜膏方的制备方法,包括以下步骤:(1)称取各组分原料,备用;(2)将当归、桂枝、党参、川芎、陈皮、焦神曲、山药、茵陈、益智仁、白胡椒、补骨脂、红枣、白芍、熟地、柴胡、酒黄精、生姜、山萸肉、枸杞子、桑寄生、韭菜子、细辛、黄芪、红花、苍术、杜仲、茯苓、艾叶、菟丝子、吴茱萸、香附放入水中浸泡10-15h;(3)将以上浸泡后的中药倒入中药机中,加入8-15倍水,煎煮3-6h,煎煮的同时进行搅拌,除去表面泡沫,过滤取出药液;(4)保留药渣,向中药机中倒入8-15倍水,煎煮3-6h,过滤取出药液,重复本步骤3次;(5)将所得的所有药液倒入锅中,加热浓缩至药液原来体积的30-50%,得到浓缩液;(6)将鹿角胶、龟甲胶、肉桂分别进行烊化处理;(7)将黄酒、龙眼肉、红糖、黑芝麻、核桃仁、以及烊化后的鹿角胶、龟甲胶、肉桂依次倒入浓缩液中,文火熬煮2-4h,得到混合液;(8)将混合液用80目筛过筛2-3次,得到混合滤液;(9)将混合滤液用文火熬煮,兑入蜂蜜,熬至膏状即可。
作为本发明进一步的方案:步骤(2)中,浸泡时间为12h。
作为本发明再进一步的方案:步骤(7)中,熬煮时间为3h。
与现有技术相比,本发明的有益效果是:1、本发明中含有多味药材,可以对人体进行全面调节,2、本发明便于分解吸收,起到温经散寒,养血通脉的作用,从根本上解决荨麻疹的发病机制,达到治疗效果。3、使用方便,易于食用,有良好的临床疗效及广阔的社会需求,4、通过大量的临床观察发现通过该药治疗荨麻疹,有效率高,不易复发,从根本上解决荨麻疹治疗后易复发的弊端,本发明具有温经散寒、养血通脉、补养肝肾、补阴阳、行气活血、脾燥湿和中、温肾散寒、疏肝解郁行气、温阳运脾的药效。
本发明主要针对血虚寒凝型荨麻疹的治疗,由于体质的相关性,治疗的出发点从体质入手,还可以用于治疗证属血虚寒凝证的:顽固性湿疹、脉管炎、带状疱疹后遗神经痛、荨麻疹(寒冷性、巨大型、丘疹性、水肿性、慢性)、过敏性紫癜、多形性红斑、雷诺氏病、手足皲裂、冻疮、寻常型银屑病、副银屑病、皮肤瘙痒症、红斑肢痛证、寒冷性脂膜炎、结节性红斑、痹证、痛经、子宫肌瘤、痛经等多种疾病。
具体实施方式
下面结合具体实施方式对本专利的技术方案作进一步详细地说明。
实施例1
本发明实施例中,一种治疗荨麻疹的养颜膏方,包括以下原料:当归10g、桂枝10g、党参10g、鹿角胶5g、川芎5g、陈皮2g、焦神曲10g、山药30g、茵陈10g、益智仁10g、白胡椒1g、补骨脂10g、红枣30g、白芍15g、熟地15g、龟甲胶2g、柴胡5g、酒黄精10g、生姜10g、山萸肉10g、枸杞子20g、桑寄生20g、韭菜子5g、细辛5g、黄芪20g、肉桂2g、红花1g、苍术2g、杜仲10g、茯苓10g、艾叶2g、菟丝子10g、吴茱萸1g、香附10g、黄酒350g、龙眼肉100g、红糖30g、黑芝麻30g、核桃仁70g、蜂蜜10g、水适量。
一种治疗荨麻疹的养颜膏方的制备方法,包括以下步骤:(1)称取各组分原料,备用;(2)将当归、桂枝、党参、川芎、陈皮、焦神曲、山药、茵陈、益智仁、白胡椒、补骨脂、红枣、白芍、熟地、柴胡、酒黄精、生姜、山萸肉、枸杞子、桑寄生、韭菜子、细辛、黄芪、红花、苍术、杜仲、茯苓、艾叶、菟丝子、吴茱萸、香附放入水中浸泡10h;(3)将以上浸泡后的中药倒入中药机中,加入8倍水,煎煮3h,煎煮的同时进行搅拌,除去表面泡沫,过滤取出药液;(4)保留药渣,向中药机中倒入8倍水,煎煮3h,过滤取出药液,重复本步骤3次;(5)将所得的所有药液倒入锅中,加热浓缩至药液原来体积的30%,得到浓缩液;(6)将鹿角胶、龟甲胶、肉桂分别进行烊化处理;(7)将黄酒、龙眼肉、红糖、黑芝麻、核桃仁、以及烊化后的鹿角胶、龟甲胶、肉桂依次倒入浓缩液中,文火熬煮2h,得到混合液;(8)将混合液用80目筛过筛2次,得到混合滤液;(9)将混合滤液用文火熬煮,兑入蜂蜜,熬至膏状即可。
实施例2
本发明实施例中,一种治疗荨麻疹的养颜膏方,包括以下原料:当归20g、桂枝20g、党参20g、鹿角胶20g、川芎20g、陈皮10g、焦神曲20g、山药50g、茵陈30g、益智仁30g、白胡椒6g、补骨脂20g、红枣60g、白芍50g、熟地40g、龟甲胶8g、柴胡15g、酒黄精30g、生姜20g、山萸肉20g、枸杞子45g、桑寄生40g、韭菜子20g、细辛20g、黄芪40g、肉桂10g、红花8g、苍术10g、杜仲20g、茯苓20g、艾叶8g、菟丝子30g、吴茱萸7g、香附20g、黄酒600g、龙眼肉200g、红糖70g、黑芝麻70g、核桃仁150g、蜂蜜20g、水适量。
一种治疗荨麻疹的养颜膏方的制备方法,包括以下步骤:(1)称取各组分原料,备用;(2)将当归、桂枝、党参、川芎、陈皮、焦神曲、山药、茵陈、益智仁、白胡椒、补骨脂、红枣、白芍、熟地、柴胡、酒黄精、生姜、山萸肉、枸杞子、桑寄生、韭菜子、细辛、黄芪、红花、苍术、杜仲、茯苓、艾叶、菟丝子、吴茱萸、香附放入水中浸泡15h;(3)将以上浸泡后的中药倒入中药机中,加入15倍水,煎煮6h,煎煮的同时进行搅拌,除去表面泡沫,过滤取出药液;(4)保留药渣,向中药机中倒入15倍水,煎煮6h,过滤取出药液,重复本步骤3次;(5)将所得的所有药液倒入锅中,加热浓缩至药液原来体积的50%,得到浓缩液;(6)将鹿角胶、龟甲胶、肉桂分别进行烊化处理;(7)将黄酒、龙眼肉、红糖、黑芝麻、核桃仁、以及烊化后的鹿角胶、龟甲胶、肉桂依次倒入浓缩液中,文火熬煮4h,得到混合液;(8)将混合液用80目筛过筛3次,得到混合滤液;(9)将混合滤液用文火熬煮,兑入蜂蜜,熬至膏状即可。
实施例3
本发明实施例中,一种治疗荨麻疹的养颜膏方,包括以下原料:当归15g、桂枝15g、党参15g、鹿角胶10g、川芎10g、陈皮5g、焦神曲15g、山药40g、茵陈20g、益智仁20g、白胡椒3g、补骨脂15g、红枣45g、白芍30g、熟地30g、龟甲胶5g、柴胡10g、酒黄精20g、生姜15g、山萸肉15g、枸杞子30g、桑寄生30g、韭菜子10g、细辛5g、黄芪30g、肉桂5g、红花3g、苍术5g、杜仲15g、茯苓15g、艾叶5g、菟丝子20g、吴茱萸3g、香附15g、黄酒500g、龙眼肉150g、红糖50g、黑芝麻50g、核桃仁100g、蜂蜜15g、水适量。
一种治疗荨麻疹的养颜膏方的制备方法,包括以下步骤:(1)称取各组分原料,备用;(2)将当归、桂枝、党参、川芎、陈皮、焦神曲、山药、茵陈、益智仁、白胡椒、补骨脂、红枣、白芍、熟地、柴胡、酒黄精、生姜、山萸肉、枸杞子、桑寄生、韭菜子、细辛、黄芪、红花、苍术、杜仲、茯苓、艾叶、菟丝子、吴茱萸、香附放入水中浸泡12h;(3)将以上浸泡后的中药倒入中药机中,加入10倍水,煎煮5h,煎煮的同时进行搅拌,除去表面泡沫,过滤取出药液;(4)保留药渣,向中药机中倒入10倍水,煎煮5h,过滤取出药液,重复本步骤3次;(5)将所得的所有药液倒入锅中,加热浓缩至药液原来体积的40%,得到浓缩液;(6)将鹿角胶、龟甲胶、肉桂分别进行烊化处理;(7)将黄酒、龙眼肉、红糖、黑芝麻、核桃仁、以及烊化后的鹿角胶、龟甲胶、肉桂依次倒入浓缩液中,文火熬煮3h,得到混合液;(8)将混合液用80目筛过筛3次,得到混合滤液;(9)将混合滤液用文火熬煮,兑入蜂蜜,熬至膏状即可。
实验例1
1、病例选择,患者年龄范围,病程时间
选取广西中医药大学第一附属医院脾胃病科门诊及治未病中心门诊患者100例,随机分为2组。治疗荨麻疹的养颜膏方组50例患者,其中男22例,女28例;年龄20-55岁,平均(38.56±15.78)岁;病程3月-36月,平均(12.45±5.07)月。西药组50例患者予氯雷他定治疗,其中男27例,女23例;年龄18-55岁,平均(37.08±14.98)岁;病程3月-35月,平均(11.45±4.25)月。
2、诊断标准简介
参照2008年第三次国际荨麻疹共识会议讨论达成的荨麻疹指南及《皮肤性病学》(第六版),拟慢性荨麻疹的诊断依据为:突然出现的风团和(或)血管性水肿,风团表现为大小不等的红斑、肿胀,伴有瘙痒、灼热感,常可在24小时内消退,不留有色素沉着,风团反复发作,每周至少两次,持续达6周及以上者,称为慢性等麻疹。
中医六经辨证属血虚寒凝之当归四逆汤证。
3、疗效评定标准:
按4级评分方法记录治疗前后的症状和体征,并计算疗效指数,同时观察不良反应。荨麻疹症状和体征的4级评分标准:①风团数目:0分为无风团;1分为风团数1~10个;2分为风团数11~20个;3分为风团数>20个,遍布全身。②风团大小:0分为无风团;1分为风团直径<1cm;2分为风团直径1~2.5cm;3分为风团直径>2。5cm。③瘙痒程度:0分为无瘙痒;1分为轻度瘙痒,不影响睡眠;2分为中度瘙痒,每晚因瘙痒觉醒次数≤2次,影响睡眠,但不影响正常生活和工作;3分为重度瘙痒,每晚因瘙痒觉醒次数≥3次或无法入睡,影响睡眠、正常生活和工作。④风团发生次数:0分为无风团;1分为风团每天出现1次;2分为风团每天出现2~3次;3分为风团每天出现>3次。⑤风团持续时间:0分为无风团;1分为风团持续时间≤h;2分为h<风团持续时间≤12h;3分为风团持续时间>12h。
疗效指数(SSRI)=[(治疗前总积分-治疗后总积分)÷治疗前总积分]×100%。痊愈为疗效指数≥90%,显效为60%≤疗效指数<90%,有效为20%≤疗效指数<60%,无效为疗效指数<20%。
4、药物使用方法
膏方组:用治疗荨麻疹的养颜膏方治疗,每天2次,每次20ml,温水兑服,共治疗4周。
西药组:氯雷他定10mg(河南天方药业股份有限公司,国药准字:H20067066,规格:10mg/片),每日1次口服,4周后观察结果。
5、临床治疗结果,以表格形式汇总
5.1两组治疗前后主要症状积分比较,见表1
表1两组治疗前后主要症状积分比较
组别 | 例数 | 治疗前 | 治疗后 | 疗效指数 |
西药组 | 50 | 13.03±3.15 | 7.16±1.54*# | 0.70±0.15# |
膏方组 | 50 | 13.10±3.09 | 4.59±1.28*# | 0.81±0.20# |
注:与西药组比较:*P<0.05,#P<0.01。治疗后,治疗荨麻疹的养颜膏方组明显改善患者主要症状(P<0.05),疗效更确切(P<0.01)。
5.2两组治疗后疗效比较见表2.
表2两组治疗前后疗效比较
组别 | 例数 | 痊愈(痊愈率) | 显效(显效率) | 有效(有效率) | 无效(无效率) | 总有效率 |
西药组 | 50 | 5(10) | 10(20) | 20(40) | 15(30) | 70% |
膏方组 | 50 | 18(36) | 22(44) | 7(14) | 3(6) | 94% |
注:与西药组比较:*P<0.01,治疗后,治疗荨麻疹的养颜膏方组治疗该病较西药组有效(P<0.01)。
临床病例:
病例1:刘某,女,50岁,工人。2017年6月6日因“反复双前臂泛发丘疹2月余”来诊。症状为:双前臂见红色丘疹,伴瘙痒,夜间加重,双脚怕冷,纳寐差,小便次数增多,大便调。舌暗红,苔白,脉沉。初步诊断:中医诊断:慢性荨麻疹。用治疗荨麻疹的养颜膏方治疗。治疗4周后症状明显改善,3个月后随访未复发。
病例2:张×,女,23岁,广西人,病程1年,因“全身瘙痒伴长红色丘疹7天”来诊,症状为:全身泛发红色丘疹,以双下肢外侧为甚,伴瘙痒,纳可,寐差,二便调。舌暗红,苔薄白,脉沉细。曾至当地医院皮肤科门诊就诊,予氯雷他定片治疗后,症状仍反复发作。诊断:急性荨麻疹,用治疗荨麻疹的养颜膏方治疗。治疗1周后症状改善,每日发作次数减少,继服膏方4周后痊愈。3个月后随访未复发。
病例3:李×,女,55岁,广西人,病程2年,症状为:全身皮肤瘙痒,以双下肢外侧为主,偶有“风团样”丘疹出现,四肢怕冷,夜寐差,纳尚可,小便清长,大便溏烂,日1次,舌暗淡,苔薄白,脉沉缓。初步诊断:瘙痒性皮肤病。患者曾四处求医问药无果,遂用治疗荨麻疹的养颜膏方治疗,治疗1月后症状明显缓解,随访2年未见复发。
病例4:陈×,男,50岁,广西靖西人,因“双下肢皮肤瘙痒伴色素沉着3年”来诊,症状为:双下肢皮肤瘙痒,纳欠佳,小便频,大便调。舌暗红,少苔,脉沉缓。查体:双下肢皮肤色素沉着,散在丘疹,伴有抓痕。诊断:慢性荨麻疹。经本发明药物施治,治疗1月后症状明显缓解,随访半年未见复发。
病例5:王×,女,49岁,广西百色人,病程6月,症状:全身散在红色斑丘疹,伴瘙痒,四肢怕冷,纳寐差,小便调,大便溏烂。舌红苔白,脉缓。诊断:慢性荨麻疹,用治疗荨麻疹的养颜膏方治疗,治疗15天后症状明显缓解,随访半年未见复发。
本发明的理论依据:
当归、桂枝、白芍、细辛——温经散寒、养血通脉
山药、熟地、益智仁、杜仲、山萸肉、桑寄生、菟丝子、补骨脂、酒黄精——补养肝肾
鹿角胶、龟甲胶、枸杞子——补阴阳
川芎、红花——行气活血
陈皮、焦神曲、苍术、茯苓——健脾燥湿和中
白胡椒、韭菜子、艾叶、黄芪、肉桂——温肾散寒
茵陈、柴胡、香附——疏肝解郁行气
生姜、吴茱萸、红枣、党参——温阳运脾
本发明具有以下疗效:
1、温经散寒、养血通脉:方中以当归四逆汤为主方,重在温经散寒,养血通脉,方中当归甘温,养血和血;桂枝辛温,温经散寒,温通血脉,为君药。细辛温经散寒,助桂枝温通血脉;白芍养血和营,助当归补益营血,共为臣药。大枣益气健脾养血,共为佐药。重用大枣,既合归、芍以补营血,又防栓枝、细辛燥烈大过,伤及阴血。全方共奏温经散寒,养血通脉之效。本方具有温阳与散寒并用,养血与通脉兼施,温而不燥,补而不滞之效。
2、补养肝肾:慢性皮肤病,久耗精血,精血不足,久则血虚化燥生风,则肤痒、脱屑,迁延不愈,故以山药、熟地、益智仁、杜仲、山萸肉、桑寄生、菟丝子、补骨脂、酒黄精众多补养肝肾之品,填精化生气血。
3、补阴阳:龟甲胶、鹿角胶血肉有情之品,补阴阳以化生精血;枸杞子补益肝肾。
4、行气活血:全方以温经散寒为主方,配以川芎、红花行气活血,加强养血通脉之功。
5、健脾燥湿和中:慢性皮肤病,病程长,伤及肝脾,故以陈皮、焦神曲、苍术、茯苓健脾和中,脾运则湿行,湿行则不能阻止气机,气血则通。
6、温肾散寒:《内经》所谓:“风雨寒热,不得虚,邪不能独伤人”“虚”是慢性荨麻疹发病的重要因素,阳虚尤其常见。虚则正不胜邪,风邪得以久居体内,导致风团反复发作,病情缠绵,肾阳乃一身元阳之根因,此白胡椒、韭菜子、艾叶、黄芪、肉桂以温补肾阳。
7、疏肝解郁行气:慢性荨麻疹以及其他慢性皮肤病,病程长,久病必伤及肝气,故以茵陈、柴胡、香附调少阳枢机,肝气条达,则脾气健运。
8、温阳运脾:配以吴茱萸汤,以温阳运脾和中。
上面对本专利的较佳实施方式作了详细说明,但是本专利并不限于上述实施方式,在本领域的普通技术人员所具备的知识范围内,还可以在不脱离本专利宗旨的前提下作出各种变化。
Claims (6)
1.一种治疗荨麻疹的养颜膏方,其特征在于,包括以下重量份数的原料:当归10-20份、桂枝10-20份、党参10-20份、鹿角胶5-20份、川芎5-20份、陈皮2-10份、焦神曲10-20份、山药30-50份、茵陈10-30份、益智仁10-30份、白胡椒1-6份、补骨脂10-20份、红枣30-60份、白芍15-50份、熟地15-40份、龟甲胶2-8份、柴胡5-15份、酒黄精10-30份、生姜10-20份、山萸肉10-20份、枸杞子20-45份、桑寄生20-40份、韭菜子5-20份、细辛5-20份、黄芪20-40份、肉桂2-10份、红花1-8份、苍术2-10份、杜仲10-20份、茯苓10-20份、艾叶2-8份、菟丝子10-30份、吴茱萸1-7份、香附10-20份、黄酒350-600份、龙眼肉100-200份、红糖30-70份、黑芝麻30-70份、核桃仁70-150份、水适量。
2.根据权利要求1所述的治疗荨麻疹的养颜膏方,其特征在于,包括以下重量份数的原料:当归15份、桂枝15份、党参15份、鹿角胶10份、川芎10份、陈皮5份、焦神曲15份、山药40份、茵陈20份、益智仁20份、白胡椒3份、补骨脂15份、红枣45份、白芍30份、熟地30份、龟甲胶5份、柴胡10份、酒黄精20份、生姜15份、山萸肉15份、枸杞子30份、桑寄生30份、韭菜子10份、细辛5份、黄芪30份、肉桂5份、红花3份、苍术5份、杜仲15份、茯苓15份、艾叶5份、菟丝子20份、吴茱萸3份、香附15份、黄酒500份、龙眼肉150份、红糖50份、黑芝麻50份、核桃仁100份、水适量。
3.根据权利要求1或2所述的治疗荨麻疹的养颜膏方,其特征在于,还包括蜂蜜10-20份。
4.一种根据权利要求3所述的治疗荨麻疹的养颜膏方的制备方法,其特征在于,包括以下步骤:(1)称取各组分原料,备用;(2)将当归、桂枝、党参、川芎、陈皮、焦神曲、山药、茵陈、益智仁、白胡椒、补骨脂、红枣、白芍、熟地、柴胡、酒黄精、生姜、山萸肉、枸杞子、桑寄生、韭菜子、细辛、黄芪、红花、苍术、杜仲、茯苓、艾叶、菟丝子、吴茱萸、香附放入水中浸泡10-15h;(3)将以上浸泡后的中药倒入中药机中,加入8-15倍水,煎煮3-6h,煎煮的同时进行搅拌,除去表面泡沫,过滤取出药液;(4)保留药渣,向中药机中倒入8-15倍水,煎煮3-6h,过滤取出药液,重复本步骤3次;(5)将所得的所有药液倒入锅中,加热浓缩至药液原来体积的30-50%,得到浓缩液;(6)将鹿角胶、龟甲胶、肉桂分别进行烊化处理;(7)将黄酒、龙眼肉、红糖、黑芝麻、核桃仁、以及烊化后的鹿角胶、龟甲胶、肉桂依次倒入浓缩液中,文火熬煮2-4h,得到混合液;(8)将混合液用80目筛过筛2-3次,得到混合滤液;(9)将混合滤液用文火熬煮,兑入蜂蜜,熬至膏状即可。
5.根据权利要求4所述的治疗荨麻疹的养颜膏方的制备方法,其特征在于,步骤(2)中,浸泡时间为12h。
6.根据权利要求4所述的治疗荨麻疹的养颜膏方的制备方法,其特征在于,步骤(7)中,熬煮时间为3h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810730242.4A CN108904766A (zh) | 2018-07-05 | 2018-07-05 | 一种治疗荨麻疹的养颜膏方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810730242.4A CN108904766A (zh) | 2018-07-05 | 2018-07-05 | 一种治疗荨麻疹的养颜膏方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108904766A true CN108904766A (zh) | 2018-11-30 |
Family
ID=64425524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810730242.4A Pending CN108904766A (zh) | 2018-07-05 | 2018-07-05 | 一种治疗荨麻疹的养颜膏方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108904766A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107441454A (zh) * | 2017-08-28 | 2017-12-08 | 杭州得卜悠健康科技有限公司 | 一种用于治疗温热蕴结的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5551848B2 (ja) * | 2001-08-09 | 2014-07-16 | ライオン株式会社 | 痒み防止皮膚外用剤 |
CN105435209A (zh) * | 2016-01-26 | 2016-03-30 | 哈药集团中药二厂 | 一种治疗荨麻疹的中药组合物 |
-
2018
- 2018-07-05 CN CN201810730242.4A patent/CN108904766A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5551848B2 (ja) * | 2001-08-09 | 2014-07-16 | ライオン株式会社 | 痒み防止皮膚外用剤 |
CN105435209A (zh) * | 2016-01-26 | 2016-03-30 | 哈药集团中药二厂 | 一种治疗荨麻疹的中药组合物 |
Non-Patent Citations (2)
Title |
---|
刘祝屏: "近代名老中医治疗慢性荨麻疹用药规律研究", 《中国博士学位论文全文数据库 医药卫生科技辑》 * |
古春青: "当归四逆汤加味临床应用举隅", 《河南中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107441454A (zh) * | 2017-08-28 | 2017-12-08 | 杭州得卜悠健康科技有限公司 | 一种用于治疗温热蕴结的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103638250B (zh) | 一种治疗面神经麻痹的中药制剂及其制备方法 | |
CN102784319B (zh) | 一种治疗气阴两虚型失眠的中药制备方法 | |
CN102166278A (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN102406798B (zh) | 用于治疗重症肌无力的中药组合物 | |
CN102366623B (zh) | 一种治疗气虚型褥疮的中药制备方法 | |
CN102526496B (zh) | 一种治疗阴虚火旺型失眠盗汗症的中药组合物及制备方法 | |
CN102805849B (zh) | 一种治疗心胆虚怯型失眠的中药制备方法 | |
CN102784372B (zh) | 一种治疗脾虚型失眠的中药制备方法 | |
CN108904766A (zh) | 一种治疗荨麻疹的养颜膏方及其制备方法 | |
CN102327442B (zh) | 一种治疗不寐型褥疮的中药洗剂制备方法 | |
CN104784346A (zh) | 一种治疗瘙痒症的中药洗剂制备方法 | |
CN102380052B (zh) | 一种治疗气阴两虚型褥疮的中药洗剂制备方法 | |
CN102380053B (zh) | 一种治疗自汗型褥疮的中药洗剂制备方法 | |
CN104013950A (zh) | 一种治疗蕴毒腐溃型褥疮的中药组合物及其制备方法 | |
CN104027784A (zh) | 一种治疗失眠的足浴袋中药组合物 | |
CN102813879B (zh) | 一种治疗瘀血型不寐的中药制备方法 | |
CN102784302A (zh) | 一种治疗肾阴亏虚型失眠的中药制备方法 | |
CN102793865B (zh) | 一种治疗胃中不和型失眠的中药制备方法 | |
CN106421113A (zh) | 一种用于预防、外治失眠的中药组合物及使用方法 | |
CN102552863B (zh) | 一种治疗纳呆型臁疮的中药制备方法 | |
CN105709176A (zh) | 一种治疗心血瘀阻型心悸的中药组合物及其制备方法 | |
CN104958705A (zh) | 一种治疗口腔溃疡的中药 | |
CN104042993A (zh) | 缓解产后便秘的中药膏剂及其制备方法 | |
CN102793901B (zh) | 一种治疗腹胀型失眠的中药制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181130 |